CanWell Pharma Inc.
CanWell Pharma Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CAN1012 in Pre-Malignant DCIS and LCIS | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Skin and Connective Tissue Diseases, adenocarcinoma, breast carcinoma in situ, breast disorder, breast neoplasm, carcinoma, ductal breast carcinoma in situ, epithelial neoplasm, in situ carcinoma, lobular breast carcinoma in situ, neoplasm, skin disorder | Recruiting | Phase 1 | 2026-09-24 | NCT07408856 | |
| CAN1012 in Pre-malignant Oral Dysplasia | Oral Epithelial Dysplasia (OED) | Not yet recruiting | Phase 1 | 2026-06-02 | NCT07620496 |